Trimodality therapy for patients with stage III non-small-cell lung cancer: A comprehensive surveillance, epidemiology, and end results analysis

Trimodality therapy for patients with stage III non-small-cell lung cancer: A comprehensive surveillance, epidemiology, and end results analysis

Purpose: Debate exists regarding the optimal management for patients with stage III non-small-cell lung cancer (NSCLC). Recent inclusion of chemotherapeutic data in the Surveillance, Epidemiology, and End Results (SEER) database has made it possible to identify patients with NSCLC who received chemo...

Full description

Bibliographic Details
Main Authors: Vincent P. Grzywacz, Thomas J. Quinn, Muayad F. Almahariq, Zaid A. Siddiqui, Sang W. Kim, Thomas M. Guerrero, Craig W. Stevens, Inga S. Grills
Format: Article
Language:English
Published: Elsevier 2022-01-01
Series:Cancer Treatment and Research Communications
Subjects:
Database
Survival
Locally advanced NSCLC
Chemoradiation
Surgery
Online Access:http://www.sciencedirect.com/science/article/pii/S2468294222000612

Internet

http://www.sciencedirect.com/science/article/pii/S2468294222000612

Similar Items